2019
DOI: 10.1590/1678-5150-pvb-5942
|View full text |Cite
|
Sign up to set email alerts
|

Abstract: Interstitial lung diseases are a group of diffuse parenchymal lung diseases that include interstitial lung fibrosis. The aim of this study is to characterize the clinical and pathological findings of idiopathic pulmonary fibrosis in three cats and to investigate possible etiological agents through bacteriological and mycological exams and immunohistochemistry. All three cats were female and aged from 10 to 14 years old, they presented with a clinical history of weight loss and dyspnea. The radiographic changes… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2022
2022

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…4 Two of three cats in another study died during surgical lung biopsy. 14 Our second case had marked respiratory compromise during bronchoscopy leading to abandonment of the procedure. This risk should be duly considered in any diagnostic work-up in a cat where PF is suspected.…”
Section: Discussionmentioning
confidence: 79%
“…4 Two of three cats in another study died during surgical lung biopsy. 14 Our second case had marked respiratory compromise during bronchoscopy leading to abandonment of the procedure. This risk should be duly considered in any diagnostic work-up in a cat where PF is suspected.…”
Section: Discussionmentioning
confidence: 79%
“…The present results suggest that cats develop fibroplasia after alveolar damage due to previous SARS-CoV-2 infection [ 8 , 13 ], which may be classified as the late fibroplasia phase, regardless of molecular SARS-CoV-2 detection. This outcome has differed from idiopathic pulmonary fibrosis in adult cats (10 to 14-year), which were negative for the presence of multiple viral etiological agents [ 14 ]. Comparatively, human cases of COVID-19 have shown alveolar regeneration initiated by the 38 th day after clinical onset [ 15 ].…”
Section: Discussionmentioning
confidence: 99%